Citation: | FANG Jiangen, WANG Xuliang, LING Jingjing, YIN Wei, XU Jinyi, JI Hui, ZHANG Yihua. Synthesis and antiplatelet aggregation/antioxidant activity of 3-alkyl-benzo[c] selenophen-1(3H)-ones[J]. Journal of China Pharmaceutical University, 2015, 46(5): 552-555. DOI: 10.11665/j.issn.1000-5048.20150506 |
[1] |
William AS,Wang X,Pancras CW.New advances in treating thrombtic diseases[J].Drug Discov Today,2014,19(9):1433-1434.
|
[2] |
Leys D,Balucani C,Cordonnier C.Antiplatelet drugs for ischemic stroke prevention[J].Cerebrovasc Dis,2009,27:120-125.
|
[3] |
Yang CY,Huang ZJ,Ling JJ,et al.Synthesis and evaluation of carbamate-isosorbide-3-n-butylphthalide ring opening derivative trihybrids as novel platelet aggregation inhibitor[J].J China Pharm Univ(中国药科大学学报),2013,44(3):202-206.
|
[4] |
Zhang Y, Wang L, Li J, et al. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia[J].J Pharmacol Exp Ther,2006,317(3):973-979.
|
[5] |
Zhu Y, Tan S. Observation of dl-3-n-butylphthalide combined edarovone treating 36 patients with progressive cerebral infarction[J].Chin J Pract Nerv Dis(中国实用神经疾病),2010,13:10-12.
|
[6] |
Wu J,Ling JJ,Wang XL,et al.Discovery of a potential anti-ischemic stroke agent:3-pentylbenzo[c]thiophen- 1(3H)one[J].J Med Chem,2012,55(16):7173-7181.
|
[7] |
Thomson CD.Assessment of requirements for selenium and adequacy of selenium status:a review[J].Eur J Clin Nutr,2004,58(3):391-402.
|